β-blocker therapy for heart failure outside the clinical trial setting: Findings of a community-based registry

American Heart Journal

Volumn 148, Issue 4, 2004, Pages 718-726

  Franciosa, Joseph A ^a,h   Massie, Barry M ^b   Lukas, Mary Ann ^c   Nelson, Jeanenne J ^c   Lottes, Sandra ^c   Abraham, William T ^d   Fowler, Michael ^e   Gilbert, Edward M ^f   Greenberg, Barry ^g  

^a Department of Obstetrics Gynecology   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c GLAXOSMITHKLINE   (United States)

^d THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^e STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h University of California San Diego ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; NITRATE; WARFARIN;

AGED; ARTICLE; BRADYCARDIA; COMMUNITY; DIABETES MELLITUS; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DIZZINESS; DRUG TOLERABILITY; FEMALE; FLUID RETENTION; FOLLOW UP; HEALTH SURVEY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPOTENSION; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHYSICIAN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REGISTER; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARBAZOLES; CARDIOLOGY; COMMUNITY HEALTH SERVICES; DIURETICS; DRUG THERAPY, COMBINATION; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PHYSICIANS, FAMILY; PROPANOLAMINES; REGISTRIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 5344247231     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.04.006     Document Type: Article

References (23)

1. Hunt S.A., Baker D.W., Chin M.H., et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 38:2001;2101-2113
2. Philbin E.F. Factors determining angiotensin-converting enzyme inhibitor underutilization in heart failure in a community setting. Clin Cardiol. 21:1998;103-108
3. Philbin E.F., Weil H.F., Erb T.A., et al. Cardiology or primary care for heart failure in the community setting process of care and clinical outcomes. Chest. 116:1999;346-354
4. Wells K.B. Treatment research at the crossroads the scientific interface of clinical trials and effectiveness research. Am J Psychiatry. 156:1999;5-10
5. Khand A., Gemmel I., Clark A.L., et al. Is the prognosis of heart failure improving? J Am Coll Cardiol. 36:2000;2284-2286
6. McCullough P.A., Philbin E.F., Spertus J.A., et al. Confirmation of a heart failure epidemic findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol. 39:2002;60-69
7. Franciosa J.A., Abraham W.T., Fowler M., et al. for the COHERE Participant Physicians. Rationale, design, and methods for a Coreg (Carvedilol) heart failure registry (COHERE). J Card Fail. 6:2000;264-271
8. Packer M., Bristow M.R., Cohn J.N., et al. for the US Carvedilol Heart Failure Study Group. The effect of Carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 334:1996;1349-1355
9. Brophy J.M., Joseph L., Rouleau J.L. β-Blockers in congestive heart failure a bayesian meta-analysis. Ann Intern Med. 134:2001;550-560
10. Greenberg B., Lottes S.R., Nelson J.J., et al. the COHERE Participant Physicians. Practical predictors of clinical outcomes in patients initiating β-blockers for heart failure findings of a community-based registry. J Am Coll Cardiol. 43:(Suppl A):2004;421A
11. Bozkurt B., Agoston I., Knowlton A.A. Complications of inappropriate use of spironolactone in heart failure when an old medicine spirals out of new guidelines. J Am Coll Cardiol. 41:2003;211-214
12. Philbin E.F., Rocco T.A., Lindenmuth N.W., et al. Clinical outcomes in heart failure report from a community hospital-based registry. Am J Med. 107:1999;549-555
13. Ansari M., Alexander M., Tutar A., et al. Cardiology participation improves outcomes in patients with new-onset heart failure in the outpatient setting. J Am Coll Cardiol. 41:2003;62-68
14. Edep M.E., Shah N.B., Tateo I.M., et al. Differences between primary care physicians and cardiologists in management of congestive heart failure relation to practice guidelines. J Am Coll Cardiol. 30:1997;518-526
15. Franciosa J.A., Abraham W.T., Fowler M., et al. and the COHERE Participant Physicians. Coreg Heart Failure Registry (COHERE) characteristics of participating physicians, their patients, and dose-titration experience. Circulation. 104:(Suppl II):2001;II-801
16. Senni M., Tribouilloy C.M., Rodeheffer R.J., et al. Congestive heart failure in the community trends in incidence and survival in a 10-year period. Arch Intern Med. 159:1999;29-34
17. Gottdiener J.S., McClelland R.L., Marshall R., et al. Outcome of congestive heart failure in elderly persons influence of left ventricular systolic function: the Cardiovascular Health Study. Ann Intern Med. 137:2002;631-639
18. Stafford R.S., Radley D.C. The underutilization of cardiac medications of proven benefit, 1990 to 2002. J Am Coll Cardiol. 41:2003;56-61
19. Goldberg R.J., Konstam M.A. Assessing the population burden from heart failure need for sentinel population-based surveillance systems. Arch Intern Med. 159:1999;15-17
20. Bangdiwala S.I., Weiner D.H., Bourassa M.G., et al. for the SOLVD Investigators. Studies of Left Ventricular Dysfunction (SOLVD) registry rationale, design, methods and description of baseline characteristics. Am J Cardiol. 70:1992;347-353
21. Shelton B.J., Wofford J.L., Gosselink C.A., et al. Recruitment and retention of physicians for primary care research. J Community Health. 27:2002;79-89
22. Croughan M. Factors influencing physician participation in practice-based research network studies a call for further research. J Fam Pract. 50:2001;978-979
23. Shibata M.C., Flather M.D., Wang D. Systematic review of the impact of β blockers on mortality and hospital admissions in heart failure. Eur J Heart Fail. 4:2001;117-120